Bank of New York Mellon’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.3M Sell
564,419
-4,480
-0.8% -$102K ﹤0.01% 1833
2026
Q1
$12.2M Sell
568,899
-18,166
-3% -$378K ﹤0.01% 1823
2025
Q4
$12.6M Sell
587,065
-14,745
-2% -$302K ﹤0.01% 1800
2025
Q3
$10.1M Sell
601,810
-3,430
-0.6% -$51.4K ﹤0.01% 1921
2025
Q2
$8.69M Sell
605,240
-3,576
-0.6% -$49K ﹤0.01% 1973
2025
Q1
$8.82M Sell
608,816
-19,461
-3% -$276K ﹤0.01% 1915
2024
Q4
$8.24M Sell
628,277
-39,413
-6% -$544K ﹤0.01% 2022
2024
Q3
$7.74M Sell
667,690
-56,185
-8% -$530K ﹤0.01% 2071
2024
Q2
$5.47M Sell
723,875
-5,465
-0.7% -$45.2K ﹤0.01% 2298
2024
Q1
$7.32M Sell
729,340
-12,094
-2% -$113K ﹤0.01% 2135
2023
Q4
$6.9M Sell
741,434
-18,483
-2% -$191K ﹤0.01% 2209
2023
Q3
$9.66M Sell
759,917
-30,002
-4% -$412K ﹤0.01% 1964
2023
Q2
$11.2M Sell
789,919
-21,237
-3% -$298K ﹤0.01% 1894
2023
Q1
$12.1M Sell
811,156
-25,750
-3% -$390K ﹤0.01% 1828
2022
Q4
$12.4M Sell
836,906
-15,185
-2% -$248K ﹤0.01% 1823
2022
Q3
$14.1M Sell
852,091
-29,071
-3% -$585K ﹤0.01% 1696
2022
Q2
$18.5M Sell
881,162
-61,618
-7% -$1.26M ﹤0.01% 1571
2022
Q1
$22.1M Sell
942,780
-38,173
-4% -$934K ﹤0.01% 1610
2021
Q4
$26.7M Sell
980,953
-39,707
-4% -$1.06M ﹤0.01% 1546
2021
Q3
$29M Sell
1,020,660
-6,644
-0.6% -$202K 0.01% 1499
2021
Q2
$31M Sell
1,027,304
-26,973
-3% -$796K 0.01% 1475
2021
Q1
$26.9M Sell
1,054,277
-457
-0% -$11.7K 0.01% 1531
2020
Q4
$25.9M Sell
1,054,734
-57,324
-5% -$1.08M 0.01% 1480
2020
Q3
$18.1M Sell
1,112,058
-90,258
-8% -$1.68M ﹤0.01% 1537
2020
Q2
$20.6M Sell
1,202,316
-80,508
-6% -$1.19M 0.01% 1423
2020
Q1
$14.9M Buy
1,282,824
+51,049
+4% +$1.05M ﹤0.01% 1471
2019
Q4
$34.2M Buy
1,231,775
+126,831
+11% +$3.18M 0.01% 1219
2019
Q3
$25M Sell
1,104,944
-112,268
-9% -$2.56M 0.01% 1403
2019
Q2
$30.7M Buy
1,217,212
+143,050
+13% +$3.84M 0.01% 1275
2019
Q1
$29.2M Sell
1,074,162
-542,956
-34% -$18.2M 0.01% 1310
2018
Q4
$53.4M Sell
1,617,118
-147,830
-8% -$5.94M 0.02% 832
2018
Q3
$82.4M Buy
1,764,948
+500,538
+40% +$23M 0.02% 710
2018
Q2
$54.7M Buy
1,264,410
+54,120
+4% +$2.59M 0.01% 944
2018
Q1
$67.3M Sell
1,210,290
-21,817
-2% -$1.2M 0.02% 810
2017
Q4
$65.8M Sell
1,232,107
-31,948
-3% -$1.51M 0.02% 836
2017
Q3
$54.5M Sell
1,264,055
-40,920
-3% -$1.94M 0.02% 929
2017
Q2
$78.8M Buy
1,304,975
+90,002
+7% +$5.33M 0.02% 700
2017
Q1
$84.3M Buy
1,214,973
+23,977
+2% +$1.67M 0.02% 665
2016
Q4
$79.4M Buy
1,190,996
+76,568
+7% +$4.98M 0.02% 668
2016
Q3
$73.8M Sell
1,114,428
-335,349
-23% -$22.9M 0.02% 673
2016
Q2
$105M Sell
1,449,777
-1,190,399
-45% -$81.8M 0.03% 507
2016
Q1
$171M Buy
2,640,176
+112,766
+4% +$7.48M 0.05% 361
2015
Q4
$181M Sell
2,527,410
-1,158,122
-31% -$85.7M 0.05% 348
2015
Q3
$283M Sell
3,685,532
-534,674
-13% -$43.1M 0.09% 239
2015
Q2
$313M Sell
4,220,206
-1,615,327
-28% -$116M 0.09% 244
2015
Q1
$423M Sell
5,835,533
-739,308
-11% -$51.4M 0.11% 202
2014
Q4
$435M Buy
6,574,841
+1,254,042
+24% +$76.5M 0.11% 191
2014
Q3
$292M Buy
5,320,799
+1,052,828
+25% +$59.7M 0.08% 269
2014
Q2
$248M Sell
4,267,971
-746,641
-15% -$43.9M 0.07% 305
2014
Q1
$311M Buy
5,014,612
+146,810
+3% +$8.54M 0.08% 245
2013
Q4
$260M Sell
4,867,802
-73,034
-1% -$3.92M 0.07% 286
2013
Q3
$248M Sell
4,940,836
-59,644
-1% -$2.91M 0.07% 278
2013
Q2
$229M Buy
+5,000,480
New +$224M 0.07% 283

Other funds holding MD

Bank of New York Mellon's MD Position: Q2 2026 in Review

Bank of New York Mellon reduced its Pediatrix Medical (MD) stake by 0.79% in Q2 2026, selling an estimated $102K and leaving 564,419 shares worth $14.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1833.

Bank of New York Mellon first reported a position in MD in Q2 2013 and has held it in 53 quarters since. The position peaked at $435M in Q4 2014. 148 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Bank of New York Mellon held 564,419 shares of Pediatrix Medical worth $14.3M as of Q2 2026.
  • Bank of New York Mellon sold 4,480 Pediatrix Medical shares in Q2 2026, an estimated $102K.
  • Pediatrix Medical made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1833 holding.
  • Bank of New York Mellon first reported a position in Pediatrix Medical in Q2 2013 and has held it in 53 quarters since.
  • Bank of New York Mellon's Pediatrix Medical position peaked at $435M in Q4 2014.
  • 148 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.